{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:36:41Z","timestamp":1792028201802,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 82570844"],"award-info":[{"award-number":["NO. 82570844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170731"],"award-info":[{"award-number":["82170731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO. 81470974"],"award-info":[{"award-number":["NO. 81470974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"High-level Hospital Construction Project of Guangdong Province","award":["DFJH201908"],"award-info":[{"award-number":["DFJH201908"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13300-026-01895-z","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:06:12Z","timestamp":1783569972000},"page":"1201-1223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Time-Averaged Serum Uric Acid and Renal Outcomes in Patients with Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Multicenter Retrospective Cohort Study"],"prefix":"10.1007","volume":"17","author":[{"given":"Shaogui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianteng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-5895","authenticated-orcid":false,"given":"Wenjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S124\u201338.","DOI":"10.2337\/dc19-S011"},{"issue":"4","key":"1895_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.kint.2020.06.024","volume":"98","author":"IH de Boer","year":"2020","unstructured":"de Boer IH, Caramori ML, Chan JCN, et al. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment. Kidney Int. 2020;98(4):839\u201348.","journal-title":"Kidney Int"},{"issue":"1","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","volume":"59","author":"DK Packham","year":"2012","unstructured":"Packham DK, Alves TP, Dwyer JP, et al. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney Dis. 2012;59(1):75\u201383.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1895_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s13300-023-01374-9","volume":"14","author":"L Zhu","year":"2023","unstructured":"Zhu L, Wang X, Sun J, et al. Hyperuricemia predicts the progression of type 2 diabetic kidney disease in Chinese patients. Diabetes Ther. 2023;14(3):581\u201391.","journal-title":"Diabetes Ther"},{"issue":"6","key":"1895_CR5","volume":"16","author":"MM Malik","year":"2024","unstructured":"Malik MM, Ganatra N, Siby R, et al. The cellular genesis of metabolic syndrome and the role of anti-urate drugs in hyperuricemia patients: a systematic review. Cureus. 2024;16(6):e62472.","journal-title":"Cureus"},{"issue":"4","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.kint.2024.05.033","volume":"106","author":"RJ Johnson","year":"2024","unstructured":"Johnson RJ, Mandell BF, Schlesinger N, et al. Controversies and practical management of patients with gout and chronic kidney disease. Kidney Int. 2024;106(4):573\u201382.","journal-title":"Kidney Int"},{"issue":"1","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12902-022-01081-9","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang Y, Ma Y, Cheng Y, et al. The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):210.","journal-title":"BMC Endocr Disord"},{"key":"1895_CR8","doi-asserted-by":"publisher","first-page":"1021267","DOI":"10.3389\/fendo.2023.1021267","volume":"14","author":"X Zhong","year":"2023","unstructured":"Zhong X, Jiao H, Zhao D, et al. Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: a case-control study. Front Endocrinol (Lausanne). 2023;14:1021267.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1895_CR9","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.2147\/DMSO.S252825","volume":"13","author":"KK Arersa","year":"2020","unstructured":"Arersa KK, Wondimnew T, Welde M, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes. 2020;13:2059\u201367.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1895_CR10","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2147\/DMSO.S423017","volume":"16","author":"X Huang","year":"2023","unstructured":"Huang X, Deng L, Huang J, et al. The ratio of serum uric acid to glycosylated haemoglobin as a predictor of all-mortality in elderly patients with diabetic foot ulcers: a longitudinal cohort study. Diabetes Metab Syndr Obes. 2023;16:2779\u201390.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1895_CR11","doi-asserted-by":"publisher","first-page":"204201882311986","DOI":"10.1177\/20420188231198620","volume":"14","author":"S Sun","year":"2023","unstructured":"Sun S, Chen L, Chen D, et al. Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study. Ther Adv Endocrinol Metab. 2023;14:20420188231198620.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1895_CR12","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.2147\/DMSO.S425511","volume":"16","author":"R Han","year":"2023","unstructured":"Han R, Duan L, Zhang Y, et al. Serum uric acid is a better indicator of kidney impairment than serum uric acid-to-creatinine ratio and serum uric acid-to-high-density lipoprotein ratio: a cross-sectional study of type 2 diabetes mellitus patients. Diabetes Metab Syndr Obes. 2023;16:2695\u2013703.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"1895_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2025.103235","volume":"56","author":"GE V\u00e1zquez-Rivera","year":"2025","unstructured":"V\u00e1zquez-Rivera GE, G\u00f3mez-Garc\u00eda EF, Parra-Michel R, et al. Single-nucleotide variants of the SLC2A9 gene are associated with hyperuricemia in Mexican patients with type 2 diabetes. Arch Med Res. 2025;56(6):103235.","journal-title":"Arch Med Res"},{"issue":"1","key":"1895_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1895_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.diabet.2019.03.001","volume":"45","author":"MY Chen","year":"2019","unstructured":"Chen MY, Wang AP, Wang JW, et al. Coexistence of hyper-uricaemia and low urinary uric acid excretion further increases risk of chronic kidney disease in type 2 diabetes. Diabetes Metab. 2019;45(6):557\u201363.","journal-title":"Diabetes Metab"},{"issue":"12","key":"1895_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41581-019-0174-z","volume":"15","author":"Y Sato","year":"2019","unstructured":"Sato Y, Feig DI, Stack AG, et al. The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD. Nat Rev Nephrol. 2019;15(12):767\u201375.","journal-title":"Nat Rev Nephrol"},{"issue":"19","key":"1895_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026301","volume":"11","author":"M Nishino","year":"2022","unstructured":"Nishino M, Egami Y, Kawanami S, et al. Lowering uric acid may improve prognosis in patients with hyperuricemia and heart failure with preserved ejection fraction. J Am Heart Assoc. 2022;11(19):e026301.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1895_CR18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/ckj\/sfac075","volume":"15","author":"G Leoncini","year":"2022","unstructured":"Leoncini G, Barnini C, Manco L, et al. Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? Clin Kidney J. 2022;15(9):1666\u201374.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1895_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02497-0","volume":"10","author":"S Nie","year":"2025","unstructured":"Nie S, Zhou S, Chen R, et al. Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. Signal Transduct Target Ther. 2025;10(1):399.","journal-title":"Signal Transduct Target Ther"},{"key":"1895_CR20","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.5114\/amsad.2021.112226","volume":"6","author":"K Mansoor","year":"2021","unstructured":"Mansoor K, Suliman M, Amro M, et al. Protective effect of allopurinol in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Arch Med Sci Atheroscler Dis. 2021;6:e196-202.","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"26","key":"1895_CR21","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","author":"A Doria","year":"2020","unstructured":"Doria A, Galecki AT, Spino C, et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med. 2020;382(26):2493\u2013503.","journal-title":"N Engl J Med"},{"issue":"26","key":"1895_CR22","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"S Badve","year":"2020","unstructured":"Badve S, Pascoe E, Tiku A, et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 2020;382(26):2504\u201313.","journal-title":"N Engl J Med"},{"issue":"6","key":"1895_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ndt\/gfae252","volume":"40","author":"X Shen","year":"2025","unstructured":"Shen X, Chen P, Liu M, et al. Long-term outcomes of IgA nephropathy in China. Nephrol Dial Transplant. 2025;40(6):1137\u201346.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1895_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727\u201338.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40795-025-01119-w","volume":"11","author":"D Liu","year":"2025","unstructured":"Liu D, Li Q, Jia R, et al. Type 2 diabetes mellitus with chronic kidney disease benefits from long-term restriction of dietary protein intake: a 10-year retrospective cohort study. BMC Nutr. 2025;11(1):131.","journal-title":"BMC Nutr"},{"issue":"10","key":"1895_CR26","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthrit Rheumatol. 2015;67(10):2557\u201368.","journal-title":"Arthrit Rheumatol"},{"key":"1895_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026677","volume":"9","author":"Q Li","year":"2019","unstructured":"Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9:e026677.","journal-title":"BMJ Open"},{"issue":"7","key":"1895_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70375","volume":"28","author":"MS Sun","year":"2025","unstructured":"Sun MS, Lyu ZH, Wang C, et al. Update of Chinese guidelines for diagnosis and treatment of hyperuricemia and gout Part I: recommendations for general patients. Int J Rheum Dis. 2025;28(7):e70375.","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"1895_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.70378","volume":"28","author":"CG Li","year":"2025","unstructured":"Li CG, Lu J, Lyu ZH, et al. Clinical practice consensus statement 2025: management of hyperuricemia and gout in adolescents. Int J Rheum Dis. 2025;28(7):e70378.","journal-title":"Int J Rheum Dis"},{"key":"1895_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.863064","volume":"10","author":"G Huang","year":"2022","unstructured":"Huang G, Li M, Mao Y, et al. Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients. Front Public Health. 2022;10:863064.","journal-title":"Front Public Health"},{"issue":"12","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"1670666","DOI":"10.3389\/fnut.2025.1670666","volume":"8","author":"TB Basnet","year":"2025","unstructured":"Basnet TB, Su Q, Gong J, et al. Dietary patterns associated with hyperuricemia among the southeast coastal Chinese population. Front Nutr. 2025;8(12):1670666.","journal-title":"Front Nutr"},{"issue":"12","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/ndt\/gfu256","volume":"29","author":"K Kamei","year":"2014","unstructured":"Kamei K, Konta T, Hirayama A, et al. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population. Nephrol Dial Transplant. 2014;29(12):2286\u201392.","journal-title":"Nephrol Dial Transplant"},{"key":"1895_CR33","doi-asserted-by":"publisher","first-page":"4002839","DOI":"10.1155\/2024\/4002839","volume":"2024","author":"F Xu","year":"2024","unstructured":"Xu F, Ma C, Wang S, et al. Higher atherogenic index of plasma is associated with hyperuricemia: a national longitudinal study. Int J Endocrinol. 2024;2024:4002839.","journal-title":"Int J Endocrinol"},{"issue":"12","key":"1895_CR34","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.3390\/nu12123835","volume":"12","author":"S Aihemaitijiang","year":"2020","unstructured":"Aihemaitijiang S, Zhang Y, Zhang L, et al. The association between purine-rich food intake and hyperuricemia: a cross-sectional study in Chinese adult residents. Nutrients. 2020;12(12):3835.","journal-title":"Nutrients"},{"key":"1895_CR35","doi-asserted-by":"publisher","first-page":"1422470","DOI":"10.3389\/fendo.2024.1422470","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qian H, Cui Y, et al. Associations between estradiol and hyperuricemia and the mediating effects of TC, TG, and TyG: NHANES 2013\u20132016. Front Endocrinol (Lausanne). 2024;15:1422470.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1895_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.kint.2024.10.022","volume":"107","author":"B Ghang","year":"2025","unstructured":"Ghang B, Park J, Lee JS, et al. Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy. Kidney Int. 2025;107(3):521\u20139.","journal-title":"Kidney Int"},{"issue":"7","key":"1895_CR37","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/biomedicines10071719","volume":"10","author":"SW Niu","year":"2022","unstructured":"Niu SW, Lin HY, Kuo IC, et al. Hyperuricemia, a non-independent component of metabolic syndrome, only predicts renal outcome in chronic kidney disease patients without metabolic syndrome or diabetes. Biomedicines. 2022;10(7):1719.","journal-title":"Biomedicines"},{"issue":"8","key":"1895_CR38","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3390\/cells9081812","volume":"9","author":"S Menini","year":"2020","unstructured":"Menini S, Iacobini C, Vitale M, et al. The inflammasome in chronic complications of diabetes and related metabolic disorders. Cells. 2020;9(8):1812.","journal-title":"Cells"},{"issue":"1","key":"1895_CR39","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1186\/s40001-025-03465-8","volume":"30","author":"F Qian","year":"2025","unstructured":"Qian F, Hong Z, Wei J, et al. Association between the serum uric acid-to-high-density lipoprotein cholesterol ratio and microalbuminuria in individuals with type 2 diabetes mellitus. Eur J Med Res. 2025;30(1):1210.","journal-title":"Eur J Med Res"},{"issue":"5","key":"1895_CR40","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2337\/db18-0912","volume":"68","author":"M Thounaojam","year":"2019","unstructured":"Thounaojam M, Montemari A, Powell F, et al. Monosodium urate contributes to retinal inflammation and progression of diabetic retinopathy. Diabetes. 2019;68(5):1014\u201325.","journal-title":"Diabetes"},{"key":"1895_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000522248","volume":"47","author":"B Wu","year":"2022","unstructured":"Wu B, Chen L, Xu Y, et al. The effect of allopurinol on renal outcomes in patients with diabetic kidney disease: a systematic review and meta-analysis. Kidney Blood Press Res. 2022;47:291\u20139.","journal-title":"Kidney Blood Press Res"},{"key":"1895_CR42","doi-asserted-by":"publisher","first-page":"F1327","DOI":"10.1152\/ajprenal.00272.2019","volume":"318","author":"SW Jung","year":"2020","unstructured":"Jung SW, Kim SM, Kim YG, et al. Uric acid and inflammation in kidney disease. Am J Physiol Renal Physiol. 2020;318:F1327\u201340.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"1895_CR43","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1016\/j.ekir.2025.08.020","volume":"10","author":"Y Lee","year":"2025","unstructured":"Lee Y, Lipkowitz MS, Kopp JB, et al. Uric acid trajectories and CKD progression in the African American study of kidney disease and hypertension. Kidney Int Rep. 2025;10(11):3893\u2013904.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"1895_CR44","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3390\/ijms23063188","volume":"23","author":"ME Gherghina","year":"2022","unstructured":"Gherghina ME, Peride I, Tiglis M, et al. Uric acid and oxidative stress relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1895_CR45","doi-asserted-by":"publisher","first-page":"2332956","DOI":"10.1080\/07853890.2024.2332956","volume":"56","author":"XH Yang","year":"2024","unstructured":"Yang XH, Zhang BL, Cheng Y, et al. Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials. Ann Med. 2024;56(1):2332956.","journal-title":"Ann Med"},{"issue":"12","key":"1895_CR46","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.ekir.2022.09.024","volume":"7","author":"IK Stanley","year":"2022","unstructured":"Stanley IK, Phoon RKS, Toussaint ND, et al. Caring for Australians and New Zealanders with kidney impairment guidelines: rapid development of urate-lowering therapy guidelines for people with CKD. Kidney Int Rep. 2022;7(12):2563\u201374.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"1895_CR47","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/ndt\/gfab237","volume":"37","author":"H Heerspink","year":"2022","unstructured":"Heerspink H, Stack A, Terkeltaub R, et al. Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia. Nephrol Dial Transplant. 2022;37(8):1461\u201371.","journal-title":"Nephrol Dial Transplant"},{"key":"1895_CR48","doi-asserted-by":"publisher","first-page":"9934190","DOI":"10.1155\/jdr\/9934190","volume":"2025","author":"C Chen","year":"2025","unstructured":"Chen C, Zhu P, Tan R, et al. Benzbromarone inhibits renal URAT1 and attenuates renal damage in streptozotocin-induced diabetic rats, independent of its uricosuric effects. J Diabetes Res. 2025;2025:9934190.","journal-title":"J Diabetes Res"},{"issue":"3","key":"1895_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40261-024-01342-6","volume":"44","author":"S Nie","year":"2024","unstructured":"Nie S, Zhao Y, Feng Z, et al. Effect of ticagrelor versus clopidogrel on all-cause and cardiovascular mortality in acute coronary syndrome patients with hyperuricemia. Clin Drug Investig. 2024;44(3):163\u201374.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"1895_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamainternmed.2024.6212","volume":"185","author":"Y Wang","year":"2025","unstructured":"Wang Y, Dalbeth N, Terkeltaub R, et al. Target serum urate achievement and chronic kidney disease progression in patients with gout and kidney disease. JAMA Intern Med. 2025;185(1):74\u201382.","journal-title":"JAMA Intern Med"},{"issue":"24","key":"1895_CR51","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295\u2013306.","journal-title":"N Engl J Med"},{"key":"1895_CR52","doi-asserted-by":"publisher","first-page":"1667438","DOI":"10.3389\/fendo.2025.1667438","volume":"16","author":"EA Habeeb","year":"2025","unstructured":"Habeeb EA, Ghaith AM, Alshehri AM, et al. Revealing the hidden impact of SGLT2 inhibitors on uric acid levels: a retrospective multicenter cohort study. Front Endocrinol (Lausanne). 2025;16:1667438.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1895_CR53","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1111\/bcp.15344","volume":"88","author":"S Najafi","year":"2022","unstructured":"Najafi S, Bahrami M, Butler AE, et al. The effect of glucagon-like peptide-1 receptor agonists on serum uric acid concentration: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(8):3627\u201337.","journal-title":"Br J Clin Pharmacol"},{"key":"1895_CR54","doi-asserted-by":"publisher","first-page":"9269085","DOI":"10.1155\/jdr\/9269085","volume":"2025","author":"X Qiao","year":"2025","unstructured":"Qiao X, Cai Q, Luo Y, et al. Longitudinal trajectories of albuminuria and eGFR in type 2 diabetes: natural progression of diabetic kidney disease. J Diabetes Res. 2025;2025:9269085.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1895_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03491-4","volume":"25","author":"Y Luo","year":"2024","unstructured":"Luo Y, Song Q, Li J, et al. Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrol. 2024;25(1):63.","journal-title":"BMC Nephrol"},{"issue":"4","key":"1895_CR56","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1895_CR57","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311x00294720","volume":"37","author":"CCR Vale","year":"2021","unstructured":"Vale CCR, Almeida NKO, Almeida RMVR. On the use of the E-value for sensitivity analysis in epidemiologic studies. Cad Saude Publica. 2021;37(6):e00294720.","journal-title":"Cad Saude Publica"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01895-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:02:06Z","timestamp":1786348926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01895-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01895-z","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Shaogui Zhang, Xuan Zhao, Jianteng Xie, Yifan Zhang, Yanhui Wang, Xiaojie Chen, Qiuling Li, Danfeng Liu, Runli Jia, Weiting He, Yaxi Zhu, Hanchen Hou, Sheng Li, Fanna Liu, Yiming Zhang, Rongshao Tan, Hongquan Peng, Jie Li, and Wenjian Wang have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of study was in accordance with the Declaration of Helsinki and approved by the institutional review board of the Guangdong Provincial People's Hospital [NO. GDREC2019513H(R1)]. This central ethics approval encompassed all eight clinical centers participating in the Southern Chinese Registration Network of Diabetic Kidney Disease (SCRENDKD) database. All authors received formal authorization from the SCRENDKD database committee to access and analyze the anonymized data for this study. All participants provided written informed consent for the collection of demographic, clinical, and laboratory data; the storage and analysis of anonymized information; and the publication of aggregated results without personal identification. All data collection, biochemical testing, and clinical management adhered to routine standard clinical practice and relevant clinical guidelines. All patient data were fully de-identified and anonymized; no individual could be identified directly or indirectly from the analyzed dataset.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}